|FOR PET OWNERS||CLINICAL SERVICES||VETERINARY PROFESSIONALS||NEWS||CONTACT US||REQUEST FORMS||JOIN OUR TEAM|
|< Back to homepage|
UK leading veterinary and scientific research charity, the Animal Health Trust (AHT), is working with other leading veterinary specialist centres (Davies Veterinary Specialists, Dick White Referra..
The team at Davies Veterinary Specialists (DVS) have saved the life of a working police dog who was critically stabbed in the line of duty last week (Sky News link: http://bit.ly/2dcL4fJ (htt..
Davies Veterinary Specialists (DVS) have confirmed their independent status with a new internal transfer of ownership and an increase in shareholding amongst colleagues. The move demonstrates the ..
A young golden Retriever, struck down by a rare disease that caused her to lose the use of her limbs overnight, has made a full recovery thanks to the dedication of her devoted owners, the skills of v..
DVS has restructured the ownership and management of the practice. Having forged an impeccable reputation over the past 12 years, the practice has welcomed new shareholders from the Directorial team, ..
The Summer 2010 newsletter incorporates DVS’s new look, which was unveiled in June. Marketing consultants Satellite Creative were appointed to refresh the practice’s logo and design theme ..
Fresh back from a trip to interventional radiology’s stateside seats of learning at the University of Pennsylvania and the Animal Medical Centre in New York, internist Ian Battersby and soft tis..
Hervé Brissot, soft tissue surgeon, explains how laparoscopic and endoscopic procedures were used for the minimally invasive treatment of a three-legged cat with chronic renal failure and a per..
UK leading veterinary and scientific research charity, the Animal Health Trust (AHT), is working with other leading veterinary specialist centres (Davies Veterinary Specialists, Dick White Referrals and Queen’s Veterinary School Hospital at University of Cambridge) on an exciting new project to combat immune-mediated haemolytic anaemia (IMHA), calling on you and your cases.
IMHA is a common haematological disease of dogs, which involves destruction of a patient’s red blood cells by their own immune system, leading to the development of anaemia. Treatment involves immunosuppression of the patient to prevent this process. Until immunosuppression is effective, patients can be supported with a range of therapies including blood transfusion to treat the anaemia. Despite the increasing availability of transfusions, mortality for patients with IMHA remains high - reported to be between 30 and 70%.
Despite the wide array of immunosuppressive treatment protocols that have been described for the treatment of IMHA, best practice remains highly controversial. It is typically accepted that corticosteroids are a mainstay of therapy, although evidence supporting this is lacking. Intravenous immunoglobulins are thought to have many potential immunomodulatory effects, and these include inhibition of phagocytosis and inhibition of complement activation, meaning that this treatment may be relatively unique in its ability to accelerate remission in IMHA.
The AHT recently received a generous donation of Pentaglobin, an IgM enriched form of hIVIG, from the family of a human patient hoping to put a surplus stock to good use. A study in new-born humans with haemolytic anaemia (Aqrabawi 2013) found that this drug was effective in rapidly inhibiting further haemolysis in most patients that received it. Currently, Pentaglobin is not a licensed or recognised veterinary treatment but human immunoglobulins have been used in veterinary patients for a number of years with some studies showing promising results. Use of Pentaglobin for this study has been approved by the Veterinary Medicines Directorate. Together with Dick White Referrals, Queen’s Veterinary School Hospital at University of Cambridge and Davies Veterinary Specialists, the AHT aims to determine if administration of Pentaglobin at the time of initial diagnosis of IMHA in dogs is beneficial for their outcome.
It is hoped that Pentaglobin will improve survival in dogs with IMHA when given in addition to conventional therapies, will induce more rapid remission and will be associated with a decreased transfusion requirement in dogs with IMHA.
As part of this multi-centre study, the collaborators need to test Pentaglobin’s effect on dogs admitted to participating hospitals that have been diagnosed with IMHA. They are asking that any cases diagnosed are highlighted to the most convenient study centre to participate in the research. Participation will be voluntary, with informed owner consent at the time of hospital admission, or once sufficient diagnostics are performed to meet the inclusion criteria. This common condition could be treated more effectively; by putting IMHA cases forward to take part in the study, you will be helping to further knowledge and understanding of treating IMHA, for the benefit of vets and their future patients.
For more information about the study and what to do if you see a case suffering from IMHA, please visit aht.org.uk/IMHA or contact your local study centre.
Mellora Sharman and Mayank Seth
Barbara Skelly and Mike Herrtage
For more detail on the current research, treatment methods and proposed study criteria and format, please contact:
Rebecca Calver, AHT press office
Tel: 01638 751 000 ext. 1572
Images can be requested from the AHT press office.
The Animal Health Trust (AHT) is an independent charity, employing over 250 scientists, vets and support workers. It aims to improve the health and welfare of horses, dogs and cats through research. It also provides specialist referral services and continuous education to vets. Visit the website at www.aht.org.uk